Population pharmacokinetic modeling of tramadol and its O-desmethyl metabolite in plasma and breast milk
- PMID: 21394525
- DOI: 10.1007/s00228-011-1023-6
Population pharmacokinetic modeling of tramadol and its O-desmethyl metabolite in plasma and breast milk
Abstract
Purpose: The aim of this investigation was to demonstrate that nonlinear mixed-effects population pharmacokinetic (PK) modeling can be used to evaluate data from studies of drug transport/excretion into human milk and hence to estimate infant exposure.
Methods: A sparse dataset from a previously published study of the use of oral tramadol for post-cesarean pain management in 75 lactating women was used. Milk and plasma samples were collected during days 2-4 of lactation, and tramadol and O-desmethyltramadol (ODT) concentration measurements in these samples were available. Absolute infant dose was obtained from the concentration measurements and estimated milk volume ingested, and expressed in micrograms per kilogram per day. Relative infant dose was calculated as a percentage of the absolute infant dose divided by the maternal dose (μg/kg/day). Nonlinear mixed-effects modeling was used to fit a population PK model to the data.
Results: The disposition of tramadol and ODT in plasma and the transition of these substances into milk were characterized by a five-compartment population PK mixture model with first-order absorption. The polymorphic ODT formation clearance in the plasma compartment was able to be characterized in both CYP2D6-poor and -extensive metabolizers. Milk creamatocrit was a significant covariate in ODT transfer between the plasma and milk compartments. The estimated relative infant doses in extensive and poor metabolizers, respectively, were 2.16 ± 0.57 and 2.60 ± 0.57% for tramadol, and 0.93 ± .20 and 0.47 ± 0.10% for ODT.
Conclusions: This study demonstrates that a population PK approach with sparse sampling of analytes in milk and plasma can yield quality information about the transfer process and that it also can be used to estimate the extent of infant exposure to maternal drugs via milk.
Similar articles
-
Population pharmacokinetic analysis of tramadol and O-desmethyltramadol with genetic polymorphism of CYP2D6.Drug Des Devel Ther. 2019 May 23;13:1751-1761. doi: 10.2147/DDDT.S199574. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31213765 Free PMC article.
-
Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.Pharmazie. 2014 Feb;69(2):138-41. Pharmazie. 2014. PMID: 24640604
-
Influence of Cytochrome P450, Family 2, Subfamily D, Polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics.Drug Metab Pharmacokinet. 2014;29(1):29-43. doi: 10.2133/dmpk.dmpk-13-rv-032. Epub 2013 Jun 11. Drug Metab Pharmacokinet. 2014. PMID: 23759977 Review.
-
Quantification in postmortem blood and identification in urine of tramadol and its two main metabolites in two cases of lethal tramadol intoxication.J Anal Toxicol. 2010 Nov;34(9):599-604. doi: 10.1093/jat/34.9.599. J Anal Toxicol. 2010. PMID: 21073815 Review.
-
Use of a sparse sampling study design to assess transfer of tramadol and its O-desmethyl metabolite into transitional breast milk.Br J Clin Pharmacol. 2008 May;65(5):661-6. doi: 10.1111/j.1365-2125.2008.03117.x. Epub 2008 Feb 20. Br J Clin Pharmacol. 2008. PMID: 18294329 Free PMC article.
Cited by
-
The MILK study: Investigating intergenerational transmission of low-calorie sweeteners in breast milk.Contemp Clin Trials Commun. 2023 Oct 12;36:101212. doi: 10.1016/j.conctc.2023.101212. eCollection 2023 Dec. Contemp Clin Trials Commun. 2023. PMID: 37881407 Free PMC article.
-
Population Pharmacokinetic Model for Tramadol and O-desmethyltramadol in Older Patients.Eur J Drug Metab Pharmacokinet. 2022 May;47(3):387-402. doi: 10.1007/s13318-022-00756-x. Epub 2022 Feb 15. Eur J Drug Metab Pharmacokinet. 2022. PMID: 35167052 Free PMC article.
-
Evaluation of the estimation and classification performance of NONMEM when applying mixture model for drug clearance.CPT Pharmacometrics Syst Pharmacol. 2021 Dec;10(12):1564-1577. doi: 10.1002/psp4.12726. Epub 2021 Oct 24. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34648691 Free PMC article.
-
Neonatal Exposure to Tramadol through Mother's Breast Milk.J Anal Toxicol. 2021 Sep 17;45(8):840-846. doi: 10.1093/jat/bkab055. J Anal Toxicol. 2021. PMID: 34037761 Free PMC article.
-
Evaluation of the Effect of CYP2D6 Genotypes on Tramadol and O-Desmethyltramadol Pharmacokinetic Profiles in a Korean Population Using Physiologically-Based Pharmacokinetic Modeling.Pharmaceutics. 2019 Nov 17;11(11):618. doi: 10.3390/pharmaceutics11110618. Pharmaceutics. 2019. PMID: 31744222 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources